Yprime Introduces New Executive Team Members

Its consulting services assist customers in streamlining downstream processes so that they may move quicker and more effectively to the next development milestone.

Fremont, CA: COVID-19 had a tremendous influence on the whole healthcare system, but it swiftly changed and began to embrace new styles of operation, including incorporating cutting-edge healthcare technology.

The pandemic caused enormous disruptions in several businesses, including manufacturing, distribution, and healthcare. COVID diagnostics and vaccinations will continue to be in high demand beyond COVID-19, placing strain on supply chains and healthcare firms to meet demand. Fortunately, the healthcare industry has begun to invest in new technologies that will assist relieve the strain of continuing to reduce COVID's impact on society in the future.

 YPrime has over ten years of expertise building cloud-based technology solutions to handle today's challenging issues while also innovating for future clinical trials. YPrime's eCOA and interactive response technology (IRT) solutions automate clinical trial data collecting and maintenance. Its experienced staff strives to provide the best possible experience for sponsors, sites, and patients. In addition, its consulting services assist customers in streamlining downstream processes so that they may move quicker and more effectively to the next development milestone.

Mohan Ganesan, Chief Financial Officer, and Alison O'Neill, Chief Operating Officer, have joined the executive team of YPrime, LLC, a global pioneer in cloud-based eClinical solutions.

As a chief financial officer, Mohan Ganesan offers financial and strategic counsel to the firm and collaborates with investors and the executive team to execute appropriate investments. In addition, Mohan oversees finances and leads the creation of defined business KPIs for finance, accounting, business operations, and human resources.

Alison O'Neill, chief operational officer, is in charge of the departments in charge of project management and the quality delivery of YPrime's goods and services. Ali has over 35 years of clinical research experience, starting as a bench chemist in the pharmaceutical sector and progressing to senior positions in worldwide companies that provide technological solutions to the industry.

"It's a real privilege to add these two experienced leaders to our executive team," says Shawn Blackburn, CEO YPrime. "We have always ensured an optimal experience for sponsors, sites, and patients. Under Mohan's leadership, we will be able to make strategic decisions about investments that will serve our clients' ever-evolving needs and measure the impact of our business. In addition, Ali's depth of expertise allows us to continue enhancing our products, processes, and services to meet the needs of these crucial stakeholders throughout a clinical trial."